Rovi Reports Q3 2024 Treasury Stock Trades
Company Announcements

Rovi Reports Q3 2024 Treasury Stock Trades

Laboratorios Farmaceuticos Rovi (ES:ROVI) has released an update.

Laboratorios Farmaceuticos Rovi reports on its third-quarter 2024 treasury stock operations under a liquidity contract with Bestinver SV, S.A., detailing trades involving over 231,000 shares purchased at an average price of 80.01 euros and over 235,000 shares sold at an average of 79.88 euros, resulting in a final securities account balance of 6,000 shares and a cash account balance of 523,209.85 euros.

For further insights into ES:ROVI stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Spain Auto-Generated NewsdeskROVI Corrects English Communication Error
TipRanks Spain Auto-Generated NewsdeskROVI Retains Control of CDMO Business for Growth
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App